Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Zardi

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Biochemical and Biophysical Research Communications|October 31, 1983
Differences in domain structure between pericellular matrix and plasma fibronectins as revealed by domain-specific antibodies combined with limited proteolysis and S-cyanylation: a preliminary noteK Sekiguchi, A Siri, L Zardi, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 1, 1996
Different human tenascin-C variants in the extracellular matrix of cultured human fibroblastsA Siri, G Allemanni, B Gaggero, et al.
The Journal of Biological Chemistry|December 1, 1995
Binding of tenascin-C to soluble fibronectin and matrix fibrilsC Y Chung, L Zardi, H P Erickson
FEBS Letters|August 7, 1995
The first untranslated exon of the human tenascin-C gene plays a regulatory role in gene transcriptionR Gherzi, M Ponassi, B Gaggero, et al.
Experimental Cell Research|March 1, 1992
Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissuesL Borsi, E Balza, G Allemanni, et al.
Clinical and Experimental Rheumatology|April 1, 1986
Altered fibronectin distribution in cultured fibroblasts from patients with Ehlers-Danlos syndromeM Cutolo, P Castellani, L Borsi, et al.
Cancer Research|February 24, 2001
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in miceF Nilsson, H Kosmehl, L Zardi, et al.
Cell Biology International|March 1, 1993
Steady-state levels of different tenascin mRNAs in various normal human tissuesL Borsi, B Carnemolla, M Ponassi, et al.
Nucleic Acids Research|February 27, 2001
Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screeningL Giovannoni, F Viti, L Zardi, et al.
International Journal of Cancer|May 29, 1996
Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cellsL Borsi, G Allemanni, B Gaggero, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|October 31, 1983
Differences in domain structure between pericellular matrix and plasma fibronectins as revealed by domain-specific antibodies combined with limited proteolysis and S-cyanylation: a preliminary noteK Sekiguchi, A Siri, L Zardi, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 1, 1996
Different human tenascin-C variants in the extracellular matrix of cultured human fibroblastsA Siri, G Allemanni, B Gaggero, et al.
The Journal of Biological Chemistry|December 1, 1995
Binding of tenascin-C to soluble fibronectin and matrix fibrilsC Y Chung, L Zardi, H P Erickson
FEBS Letters|August 7, 1995
The first untranslated exon of the human tenascin-C gene plays a regulatory role in gene transcriptionR Gherzi, M Ponassi, B Gaggero, et al.
Experimental Cell Research|March 1, 1992
Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissuesL Borsi, E Balza, G Allemanni, et al.
Clinical and Experimental Rheumatology|April 1, 1986
Altered fibronectin distribution in cultured fibroblasts from patients with Ehlers-Danlos syndromeM Cutolo, P Castellani, L Borsi, et al.
Cancer Research|February 24, 2001
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in miceF Nilsson, H Kosmehl, L Zardi, et al.
Cell Biology International|March 1, 1993
Steady-state levels of different tenascin mRNAs in various normal human tissuesL Borsi, B Carnemolla, M Ponassi, et al.
Nucleic Acids Research|February 27, 2001
Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screeningL Giovannoni, F Viti, L Zardi, et al.
International Journal of Cancer|May 29, 1996
Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cellsL Borsi, G Allemanni, B Gaggero, et al.
Pageof 14